lactic acid and mobic

lactic acid has been researched along with mobic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Barcia, E; Fernández-Carballido, A; Montejo, C; Negro, S1
Dogan, AL; Esendagli, G; Gönül, N; Guc, D; Hasçiçek, C; Şengel-Türk, CT1
Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, AA; Nutan, MT; Rahman, Z; Samy, AM1
Aguilera-Aguilera, R; Buzon-Cuevas, A; Gonzalez-De Cara, C; Mendoza Garcia, FJ; Perez-Ecija, A1

Other Studies

5 other study(ies) available for lactic acid and mobic

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.
    International journal of pharmaceutics, 2010, Mar-15, Volume: 387, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Thiazines; Thiazoles; Time Factors

2010
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Agents; Biological Transport; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Stability; HT29 Cells; Humans; Kinetics; Lactic Acid; Meloxicam; Molecular Weight; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Solubility; Surface Properties; Thiazines; Thiazoles

2012
Development of meloxicam in situ implant formulation by quality by design principle.
    Drug development and industrial pharmacy, 2014, Volume: 40, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Gels; Inhibitory Concentration 50; Lactic Acid; Male; Meloxicam; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Thiazines; Thiazoles; Viscosity; X-Ray Diffraction

2014
Meloxicam ameliorates the systemic inflammatory response syndrome associated with experimentally induced endotoxemia in adult donkeys.
    Journal of veterinary internal medicine, 2020, Volume: 34, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Endotoxemia; Equidae; Female; Interleukin-1beta; Lactic Acid; Lipopolysaccharides; Meloxicam; Monocytes; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2020